.INVESTIGATION HIGHLIGHT.06 August 2024.
A large randomized regulated test along with cisgender women highlights the problems of fidelity to a day-to-day dental preexposure prevention regiment and illustrates that twice-yearly treatment of lenacapavir can sustain reliable HIV avoidance amounts over 6 months.